Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response-Adapted Sequential Azacitidine and Chemotherapy in Elderly AML
DRKS00004519Phase 2Completed
- Sponsor
- Leipzig University
- Start
- Nov 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of azacitidine in acute myeloid leukemia (AML) (2 arms), sponsored by Leipzig University. Started Nov 2012; status: completed.
02
Drugs
azacitidine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on DRKS00004519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00004519.